Assessment of IL-12 and Liver Enzymes Levels in Serum of Some Iraqi Patients with Colon Cancer
DOI:
https://doi.org/10.25130/tjphs.2025.19.1.3.30.40Keywords:
Colon cancer, Interleukin-12, AST, ALT, ALP, IraqAbstract
Background: Interleukin-12 has extensively studied in colorectal cancer, but its correlation with liver enzymes is still limit.
Objective: the present study aimed to assess the serum levels of Interleukin-12 and liver enzymes in Iraqi patients with colon cancer.
Methods: Serum samples (90) were collected divided to 50 samples of colorectal cancer CRC patients and 40 of healthy subjects, interleukin-12 was measured using ELISA, while liver enzymes were measured spectrophotometrically and statistically analyzed.
Results: The study showed significant increase (P˂0.0001) in concentration of IL-12 (304.6±26.91) pg/ml, ALP (309.9±66.84) IU/L, AST (323.5±109.9) IU/L and ALT (37.4±7.78) IU/L compared to healthy subjects (142.3±14.71 pg/ml, 165.5±38.8 IU/L, 152.6±55.34 IU/L, and 18.28±6.14 IU/L) respectively for all biomarkers. .
Conclusion: Iraqi patients with CRC show elevated serum IL-12 and elevated lever enzymes, however, liver enzymes work independently and not affected by IL-12.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 THIS IS AN OPEN ACCESS ARTICLE UNDER THE CC BY LICENSE http://creativecommons.org/licenses/by/4.0/

This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access journal, and all journal content is available for readers free of charge immediately upon publication.